We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

30 hedge funds and large institutions have $1.13M invested in Lunai Bioworks in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% less ownership

Funds ownership: 0.07% → 0.04% (-0.03%)

25% less funds holding

Funds holding: 40 → 30 (-10)

63% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 16

63% less capital invested

Capital invested by funds: $3.02M → $1.13M (-$1.9M)

78% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 18

Holders
30
Holders Change
-10
Holders Change %
-25%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
18
Closed
16
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$206K
2
HFRG
Houlihan Financial Resource Group
Virginia
+$193K
3
Goldman Sachs
Goldman Sachs
New York
+$100K
4
Jane Street
Jane Street
New York
+$79.7K
5
YIH
Y-Intercept (HK)
Hong Kong
+$41.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$939K
2
State Street
State Street
Massachusetts
-$245K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$156K
4
Northern Trust
Northern Trust
Illinois
-$131K
5
Nuveen
Nuveen
North Carolina
-$111K

LNAI Hedge Fund Activity: Q2 2023 in Review

30 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2023, worth a combined $1.13M — down 63% from $3.02M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LNAI and 6 opened new positions — a net loss of 10 holders — while 18 trimmed existing stakes and 4 added.

The largest buyer was Millennium Management, adding an estimated $206K. The largest seller was BlackRock, cutting an estimated $939K.

  • 30 institutional investors held Lunai Bioworks (LNAI) as of Q2 2023, down from 40 in Q1 2023.
  • Funds reported $1.13M of Lunai Bioworks stock for Q2 2023, down 63% quarter-over-quarter.
  • 6 funds opened new Lunai Bioworks positions in Q2 2023 and 16 closed out, a net change of -10 holders.
  • The largest Lunai Bioworks buyer in Q2 2023 was Millennium Management, an estimated $206K added.
  • The largest Lunai Bioworks seller in Q2 2023 was BlackRock, an estimated $939K sold.

Based on aggregated 13F filings for Q2 2023.